Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Operating Leases (2018 - 2025)

Fresenius Medical Care AG (FMS) has 5 years of Operating Leases data on record, last reported at $21.1 million in Q4 2025.

  • For Q4 2025, Operating Leases rose 223.42% year-over-year to $21.1 million; the TTM value through Dec 2025 reached $21.1 million, up 223.42%, while the annual FY2025 figure was $20.5 million, 209.92% up from the prior year.
  • Operating Leases reached $21.1 million in Q4 2025 per FMS's latest filing, up from $6.5 million in the prior quarter.
  • Across five years, Operating Leases topped out at $116.4 million in Q4 2022 and bottomed at $6.5 million in Q4 2024.
  • Average Operating Leases over 4 years is $50.6 million, with a median of $39.7 million recorded in 2021.
  • Peak YoY movement for Operating Leases: soared 99.5% in 2022, then surged 223.42% in 2025.
  • A 4-year view of Operating Leases shows it stood at $58.3 million in 2021, then surged by 99.5% to $116.4 million in 2022, then plummeted by 94.4% to $6.5 million in 2024, then soared by 223.42% to $21.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $21.1 million in Q4 2025, $6.5 million in Q4 2024, and $116.4 million in Q4 2022.